shire map
Select a

Shire Global

Better Health, Brighter Future

Directorate Change

Dublin, Ireland – January 19, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Thomas Dittrich will assume his role as Chief Financial Officer, and become an Executive member of the Board of Directors and a member of the Executive Committee, on March 19, 2018.

This announcement is made in compliance with LR 9.6.12.

For further information please contact:

Investor Relations  
Christoph 795 432 359
Sun 617 588 8175
Robert 203 549 0874
Lisa 617 588 8607
Katie 781 482 2779


About Shire

Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people’s lives with medicines that have a meaningful impact on patients and all who support them on their journey.


Cookie Use Notification

The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies. LEARN MORE